Skip to main content
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
As of Apr 2
PoliticsUnited States1 sourcesNeutral

Trump’s MFN Pricing Expected To Delay More European Drug Launches

Following Insmed’s decision to hold off on launching a newly approved lung disease drug in Europe, experts anticipate more companies will do the same as they seek to avoid price erosion in the U.S. Will Chinese biotechs fill the void?

NP
nick paul taylor
via Biospace
ShareRead original

Read the full article at Biospace →

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Biospace
Biospace
NewsDataUS

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
Gyokeres to the rescue as Sweden beat Poland in thriller to reach World Cup
Next
ORNL to Feature Transformative Tech at ARPA-E Summit

Related Articles

Trump Moves Look Like 'Putin’s Dream Plan'—Key NATO AllyPolitics
Trump Moves Look Like 'Putin’s Dream Plan'—Key NATO Ally
Matt Cannon-2h ago-1 sources
Scott Jennings Took the CNN Panel to School on Birthright Citizenship and NATO Last NightPolitics
Scott Jennings Took the CNN Panel to School on Birthright Citizenship and NATO Last Night
Matt Vespa-2h ago-1 sources
Indian Shares Resume Downward Trend After Trump's SpeechPolitics
Indian Shares Resume Downward Trend After Trump's Speech
Unknown-8h ago-1 sources